In order to study the clinical relevance of DACH1 expression and lung cancer development, this study enrolled 36 patients diagnosed with lung adenocarcinoma ranged from 45 to 74 years, and the mean age at the time of surgery was 58.0 years. The gene discussed is DACH1; the disease is lung carcinoma.